The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-25-016 |
| Conservation Collaboration Cooperative Agreements Fiscal Year (FY) 2024 Announcement for Program Funding - NORTH DAKOTA |
10.902 |
USDA-NRCS-ND-MULTI-24-NOFO0001325 |
| Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) |
93.853, 93.866 |
PAR-24-148 |
| Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed) |
93.853, 93.866 |
PAR-24-147 |
| NIJ FY24 Research and Evaluation on Hate Crimes |
16.560 |
O-NIJ-2024-171949 |
| NIJ FY24 Research and Evaluation on Firearm Violence and Mass Shootings |
16.560 |
O-NIJ-2024-171966 |
| GPD Program Special Need Grant |
64.024 |
VA-GPD-SN-FY2025 |
| NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) |
93.113, 93.121, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-24-030 |
| Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) |
93.213 |
PAR-24-123 |
| NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) |
93.213 |
PAR-24-115 |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
93.213 |
PAR-24-116 |
| P24AS00251 - 2024 Route 66 Corridor Preservation Program |
15.958 |
P24AS00251 |
| NIJ FY24 Research and Evaluation of Services for Victims of Crime |
16.560 |
O-NIJ-2024-171964 |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) |
93.213 |
PAR-24-124 |
| NIJ FY24 Research and Evaluation on Violence Against Women |
16.560 |
O-NIJ-2024-171963 |
| Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional |
93.103 |
RFA-FD-24-038 |
| Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required) |
93.847 |
RFA-DK-23-011 |
| NIJ FY24 Longitudinal Research on Delinquency and Crime |
16.560 |
O-NIJ-2024-171957 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
93.855 |
PAR-24-100 |
| Climate Smart Conservation Collaboration - SOUTH CAROLINA |
10.902 |
USDA-NRCS-SC-MULTI-24-NOFO0001344 |
| Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not Allowed) |
93.279 |
RFA-DA-25-034 |
| Fiscal Year 2024 Targeted Violence and Terrorism Prevention Grant Program |
97.132 |
DHS-24-TTP-132-00-99 |
| Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Basic Experimental Studies with Humans (BESH) Required) |
93.279 |
RFA-DA-25-033 |
| Conservation Collaboration Grant Agreements Fiscal Year (FY) 2024 Announcement for Program Funding - NORTH DAKOTA |
10.902 |
USDA-NRCS-ND-MULTI-24-NOFO0001326 |
| Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trial Optional) |
93.279 |
RFA-DA-25-032 |
| Fiscal Year 2024 Capital Magnet Fund Program |
21.011 |
CDFI-2024-CMF |
| Homeless Veterans' Reintegration Program (HVRP), Incarcerated Veterans' Transition Program (IVTP), and the Homeless Women Veterans' and Homeless Veterans' with Children Reintegration Grant Program (HWVHVWC) (referred to |
17.805 |
FOA-VETS-24-50 |
| Implementing Evidence-Based Health Promotion Programs for Attention-Deficit Hyperactivity Disorder (ADHD) or Tourette Syndrome (TS) |
93.073 |
CDC-RFA-DD-24-0055 |
| Grants to Expand Substance Use Disorder Treatment Capacity in Adult and Family Treatment Drug Courts |
93.243 |
TI-24-004 |
| Ensuring Research Integrity - Conferences |
93.085 |
IR-ORI-24-001 |
| Behavioral Risk Factor Surveillance System (BRFSS): Impact on Population Health |
93.336 |
CDC-RFA-DP-24-0023 |
| Community Economic Development Planning Grants |
93.570 |
HHS-2023-ACF-OCS-EE-0056 |
| FY24 Bureau of Land Management Oregon/Washington (ORWA) Secure Rural Schools Title II |
15.234 |
L24AS00113 |
| Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-24-003 |
| Evaluation and Coordinating Center for the AHRQ/PCORI Learning Health System Embedded Scientist Training and Research Centers (U18) |
93.226 |
RFA-HS-24-002 |
| Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed) |
93.855 |
PAR-24-111 |
| Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed) |
93.855 |
PAR-24-112 |
| 2024 Enhancing Statewide Falls Prevention Awareness, Strategy, and Collaboration |
93.761 |
HHS-2024-ACL-AOA-FPSG-0036 |
| Hydrogen and Fuel Cell Technologies Office FOA to Advance the National Clean Hydrogen Strategy |
81.087 |
DE-FOA-0003213 |
| Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional) |
93.113, 93.121, 93.213, 93.233, 93.242, 93.273, 93.279, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.866 |
RFA-NR-24-004 |
Search Results 281-320 of 17636
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next] |
